Cargando…

Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches

Standing amidst the COVID-19 pandemic, we have faced major medical and economic crisis in recent times which remains to be an unresolved issue till date. Although the scientific community has made significant progress towards diagnosis and understanding the disease; however, effective therapeutics a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Amrita, Verma, Ayushi, Bihani, Surbhi, Burli, Ananya, Mantri, Krishi, Srivastava, Sanjeeva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222565/ https://www.ncbi.nlm.nih.gov/pubmed/34906319 http://dx.doi.org/10.1016/j.ddtec.2021.06.004

Ejemplares similares

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
por: Suvarna, Kruthi, et al.
Publicado: (2021)

Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
por: Mukherjee, Amrita, et al.
Publicado: (2022)

Humoral Immune Response Profile of COVID-19 Reveals Severity and Variant-Specific Epitopes: Lessons from SARS-CoV-2 Peptide Microarray
por: Acharjee, Arup, et al.
Publicado: (2023)

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
por: Deshpande, Rujuta R., et al.
Publicado: (2020)

Structure- and Ligand-Based in silico Studies towards the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2
por: Fayed, Marwa A.A., et al.
Publicado: (2021)

In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
por: Zaki, Magdi E. A., et al.
Publicado: (2023)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19
por: Bankar, Renuka, et al.
Publicado: (2021)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021)

Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight
por: Begum, Feroza, et al.
Publicado: (2021)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
por: Shah, Bhumi, et al.
Publicado: (2020)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
por: Akinlalu, Alfred Olaoluwa, et al.
Publicado: (2021)

Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From in silico to in vitro Validation
por: Alexpandi, Rajaiah, et al.
Publicado: (2022)

In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
por: Zapata-Cardona, Maria I., et al.
Publicado: (2023)

Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing
por: Wang, Zichen, et al.
Publicado: (2020)

Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii
por: Cajazeiro, Débora Chaves, et al.
Publicado: (2022)

Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples
por: Banerjee, Arghya, et al.
Publicado: (2022)

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing
por: Tristán-Flores, Fabiola E, et al.
Publicado: (2021)

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies
por: Rabie, Amgad M., et al.
Publicado: (2022)

Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
por: Yu, Wenhui, et al.
Publicado: (2022)

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
por: Santos, Jennifer, et al.
Publicado: (2020)

Repurposing current therapeutic regimens against SARS-CoV-2 (Review)
por: K. Konstantinidou, Sofia, et al.
Publicado: (2020)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics
por: Le Daré, Brendan, et al.
Publicado: (2021)

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repurposing Approaches towards the Discovery of Effective BH(4) Therapeutics
por: Hussein, Dania
Publicado: (2023)

Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study
por: Ferraz, Witor Ribeiro, et al.
Publicado: (2020)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022)

Quantitative proteomic comparison of stationary/G(0) phase cells and tetrads in budding yeast
por: Kumar, Ravinder, et al.
Publicado: (2016)

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
por: Firestone, Tessa M., et al.
Publicado: (2021)

Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
por: Rampogu, Shailima, et al.
Publicado: (2021)

Computational guided approach for drug repurposing against SARS-CoV-2
por: Anand, Jigisha, et al.
Publicado: (2021)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach
por: Sahu, Anshuman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bqiisji6qflafp9ssj0ijhe7q1